Although uptake was limited, prophylactic treatment with moxifloxacin was well-tolerated in individuals with evidence of latent tuberculosis who were in contact with patients with high-risk multidrug-resistant tuberculosis.
Delafloxacin may provide a feasible alternative antibiotic monotherapy option for treating patients with community-acquired bacterial pneumonia (CABP) who have renal impairment in both inpatient and outpatient settings.
Lefamulin appears to be noninferior in safety and efficacy compared with moxifloxicin in the treatment of community-acquired bacterial pneumonia.
In conjunction with its release of the adult guidelines earlier this year, the ACIP earlier this year has issued an annual update on pediatric immunization schedules.
In light of Immunization Awareness Month, the American College of Physicians has issued a press statement to remind adults of the importance of staying up to date on all recommended vaccinations.
In patients who are immunocompromised, such as people living with HIV, the new fourth-generation QuantiFERON-TB Gold Plus assay demonstrated similar sensitivity to the third-generation interferon-gamma release assay for the diagnosis of latent tuberculosis.
There are still significant gaps in knowledge and research advancement on outbreaks of
infection with Cyclospora cayetanensis.
WHO leads its annual campaign, SAVE LIVES: Clean Your Hands, to increase global awareness of the importance of hand hygiene among healthcare workers.
A freeze-dried, temperature-stable, experimental tuberculosis vaccine candidate has entered a phase 1 human clinical trial.
Patients with bacterial pneumonia are at higher risk for major adverse cardiovascular events within 90 days compared with patients with viral pneumonia.
